(R)-1-(4-methoxyphenyl)-4-(1-phenoxypropan-2-yloxy)pyridin-2(1H)-one

ID: ALA4574649

PubChem CID: 155563969

Max Phase: Preclinical

Molecular Formula: C21H21NO4

Molecular Weight: 351.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-n2ccc(O[C@H](C)COc3ccccc3)cc2=O)cc1

Standard InChI:  InChI=1S/C21H21NO4/c1-16(15-25-19-6-4-3-5-7-19)26-20-12-13-22(21(23)14-20)17-8-10-18(24-2)11-9-17/h3-14,16H,15H2,1-2H3/t16-/m1/s1

Standard InChI Key:  NUESXZYGSOAJKX-MRXNPFEDSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   11.2123   -5.2993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2111   -6.1189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9192   -6.5278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6288   -6.1184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6260   -5.2957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9174   -4.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3322   -4.8845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0414   -5.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7476   -4.8791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4568   -5.2851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1630   -4.8738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8682   -5.2806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5722   -4.8728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5734   -4.0553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8643   -3.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1540   -4.0566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8640   -2.8300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2811   -3.6467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9855   -4.0584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6927   -3.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6932   -2.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9805   -2.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2762   -2.8343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7445   -4.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4004   -2.4229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1086   -2.8306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 16  2  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  9 24  1  1
 21 25  1  0
 25 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4574649

    ---

Associated Targets(non-human)

Grm3 Metabotropic glutamate receptor 3 (981 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 351.40Molecular Weight (Monoisotopic): 351.1471AlogP: 3.69#Rotatable Bonds: 7
Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.52CX LogD: 3.52
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.65Np Likeness Score: -0.86

References

1. Yamada Y, Yohn SE, Gilliland K, Loch MT, Schulte ML, Rodriguez AL, Blobaum AL, Niswender CM, Conn PJ, Lindsley CW..  (2019)  Further exploration of an N-aryl phenoxyethoxy pyridinone-based series of mGlu3 NAMs: Challenging SAR, enantiospecific activity and in vivo efficacy.,  29  (18): [PMID:31358468] [10.1016/j.bmcl.2019.07.030]

Source